baber/WOPTO huggingface dataset:
Patent NZ-523848-A (NZ)
Title: A scalable low-latency switch for usage in an interconnect structure
Inventor: HESSE JOHN E
IPC: H04L45/02
Filed: 1998-01-22
Abstract: An interconnect structure S containing a plurality of nodes and a plurality of interconnects selectively coupling the nodes, comprises: a node set T, an interconnect set I that selectively connects nodes in the node set T; a device set A mutually exclusive of the node set T with the devices in device set A which capable of sending data to one or more nodes in the node set T; a device set Z mutually exclusive of the node set T with the device in device set Z which capable of receiving data to one or more nodes in the node set T; and a collection C of node subsets of the node set T, each node in the node set T is contained in exactly one member of the collection C such that: for a device x in the device z , a sequence cx = cz 0, cz 1, cz 2 . cz J exists with each member of the sequence cx is a node set in the collection C, the sequence cx is capable passing data from devices in the device set A to the device x on a plurality of paths, among the plurality of paths being a path set P(x) characterised in that a path R is included in the paths set P(x) only if each node on the path R is in a member of the sequence cx, anode of the path R that receives a message directly from a device in devices set A being a member of node set cx U and a node of the path R that sends data directly to he device x being a member of node set cx v with U being larger than V; for a member Q of the collection C, a corresponding set of devices Z(Q) exists in the device plurality Z such that a device q is included in the set Z(Q) only if the member Q is also a member of the sequence cq: for members cx H and cx K of the sequence cx with H > K, a device set Z (cx K) is a subset of a device Z (cx H) and a device exists in device set Z (cx H) that is not included in the device set (cx k); and the node set T includes three distinct nodes p,q and r , the node p being in a member cz D of the sequence cz , the nodes q,r being in a member cz E with D > E , in one path of the plurality of paths P(x) a message moves directly from the node p to the node r and in another path of the plurality of paths P(x) a message moves directly from the node q to the node r. (62) Divided out of 512979
Patent NZ-526961-A (NZ)
Title: 6-substituted pyrido-pyrimidines
Inventor: CHEN JIAN JEFFREY
IPC: A61P9/00
Filed: 2002-02-04
Abstract: Disclosed are compounds of formula I or II, wherein: Z is N or CH, W is NR2, X1 is O, NR4, S or CR5R6, X2 is O or NR7, Ar1 is aryl or heteroaryl, R2 is H, alkyl, haloalkyl, acyl, alkoxycarbonyl, aryloxycarbonyl, heteroalkylcarbonyl, heteroalkyloxycarbonyl or -R21-R22, R1 is hydrogen, alkyl, haloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, cycloalkyl, cycloalkylalkyl, heteroalkylsubstituted cycloalkyl, heterosubsittiuted cycloalkyl, heteroalkyl, cyanoalkyl, heterocyclyl, heterocyclylalkyl, R12-SO2- heterocycloamino, -Y1-C(O)-Y2-R11, (heterocyclyl)(cycloalkyl)alkyl or (heterocyclyl)(heteroaryl)alkyl, R3 is hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, haloalkyl, heteroalkyl, cyanoalkyl, alkylene-C(O)-R31, amino, monoalkylamino, dialkylamino, NR32-Y3-R33, or acyl, R7 is H or alkyl, and R8 and R9 are independently H, alkyl, aryl, aralkyl, cycloalkyl, cycloalkylalkyl, heteroalkyl, alkylsulfonyl, arylsulfonyl, - C(O)-R81, or R8 and R9 together form CR82R83. The compounds are used in the manufacture of medicaments for the treatment of p38 mediated disorders.
Patent NZ-528076-A (NZ)
Title: Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists with an immunomodulatory agents, anti-inflammatory agents, TNF-alpha antagonists or CD2 binding molecules
Inventor: DINGIVAN CHRISTINE
IPC: A61K31/192
Filed: 2002-03-04
Abstract: As synergistic composition comprises an intergrin alphaVbeta3 antagonist, which is an antibody that immunospecifically binds to intergrin alphaVbeta3, and either a small organic molecule, which is a immunomodulatory agent or a T cell or cytokine receptor modulator, a non-steroidal anti-inflammatory drug, or a peptide, such as endostatin, angiostatin, apomigren, prolcatin and fibronectin. The compositions are useful for the treatment of inflammatory and autoimmune disorders.
Patent NZ-528625-A (NZ)
Title: Improvements to a single use syringe
Inventor: KIEHNE BRUCE LEIGH
IPC: A61M5/158
Filed: 2002-05-17
Abstract: Disclosed is a single use syringe which uses a "pinching" action between a specially designed plunger 12 and a needle holder 14 to shoot the needle 13 back into the syringe body upon completion of the piston stroke. The needle holder 14 is held by friction against the face of the syringe. Holder 14 is not biased by a spring and the needle 13 remains in a normal extended position condition until the plunger is pushed against the needle holder creating the pinching action to shoot the needle back into the syringe body through membrane 52.
Patent NZ-530044-A (NZ)
Title: Dry powder inhalation system for transpulmonary administration
Inventor: YAMASHITA CHIKAMASA
IPC: A61K47/20
Filed: 2002-06-14
Abstract: A dry powder inhalation system for transpulmonary administration has a combination of: (1) a vessel housing a freeze-dried composition that contains a single dose of an active ingredient, and has (i) a non-powder cake-like form, (ii) a disintegration index of 0.015 or more, and (iii) a property of becoming fine particles having a mean particle diameter of 10 microns or less or a fine particle fraction of 10% or more upon receiving an air impact having an air speed of at least 1 m/sec and an air flow rate of at least 17 ml/sec; and (2) a device comprising means capable of applying the air impact to the freeze-dried composition in the vessel, and means for discharging the powder-form freeze-dried composition that has been made into fine particles.
Patent NZ-530079-A (NZ)
Title: Process for the protection of reinforcement in reinforced concrete
Inventor: GLASS GARETH KEVIN
IPC: C23F13/02
Filed: 2003-12-10
Abstract: A process for reducing corrosion of steel reinforcement in concrete in which the process comprises of passing a direct electric current between an anode and the reinforcement as cathode before the concrete has hardened thereby forming a deposit of solid alkali at the steel surface and the layer being at least 1 micron in thickness and covering at least 20 percent of the steel surface. (62) Divided out of 520344
Patent NZ-533005-A (NZ)
Title: Fixing apparatus
Inventor: HALL JACOB R
IPC: B62J6/02
Filed: 2004-05-18
Abstract: With an aim to provide a fixing apparatus capable of maintaining strong fixation with a simplified mechanism in a stable manner for a long time, a fixing apparatus fixing a headlamp to an object includes a plurality of arms having one end connected to each other, having free another end, and capable of changing a range of enclosure so as to grasp the object, a base member supporting the connected plurality of arms, and a nut changing a position relative to the base member, engaging to the base member, and pressing its edge against the plurality of arms to change an angle of enclosure by the arms.
Patent NZ-533418-A (NZ)
Title: Bandage for wound or incision closure
Inventor: LEBNER MICHAEL
IPC: A61B17/08
Filed: 2002-12-11
Abstract: Disclosed is a bandage (1) for closing a wound or incision, and methods for the use of same. The bandage comprises a first flat flexible component (5) having adhesive on a lower surface and one or more first elongated connectors (15) extending in an offset manner from one edge thereof in a first direction. The bandage further comprises a second flat flexible component (25) having adhesive on a lower surface and one or more second elongated connectors (35) extending in an offset manner from one edge thereof in a second direction generally opposite to the first direction. Pulling elements (40, 45) are joined to the first and second elongated connectors. Means are provided for attaching the first elongated connectors to the second flat flexible component and the second elongated connectors to the first flat flexible component.
Patent NZ-535773-A (NZ)
Title: Novel curcumin analogues and uses thereof
Inventor: LEE KUO-HSIUNG
IPC: C07C49/248
Filed: 2003-03-27
Abstract: Disclosed is a compound according to formula I wherein: R1 and R2 are each independently selected from the group consisting of alkoxy, nitro, amino, and dialkylamino; R3 and R4 are each independently selected from the group consisting of hydroxy, alkoxy, and -OR7C(O)R8 wherein R7 is lower alkylene and R8 is alkoxy; or R1 and R3 together are alkylenedioxy; or R2 and R4 together are alkylenedioxy; R5 and R6 are each independently selected from the group consisting of H, halogen, and nitro; X1 is N, or X is C bonded to a H, alkoxy or nitro; and X2 is N, or X is C bonded to a H, alkoxy or nitro. Compounds of the type disclosed are androgen receptor agonists and are useful in the treatment of cancer.
Patent NZ-538427-A (NZ)
Title: Novel benzomidazole derivatives useful as antiproliferative agents for treating cancer
Inventor: KATH JOHN CHARLES
IPC: C07D405/14
Filed: 2003-08-14
Abstract: Disclosed herein is a compound selected from the group consisting of: (±)-1-{2-[5-(Tetrahydro-furan-3-yloxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine; (+)-1-{2-[5-(Tetrahydro-furan-3-yloxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine; (-)-1-{2-[5-(Tetrahydro-furan-3-yloxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine; 1-{2-[5- (3-Methyl-oxetan-3-ylmethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine; 1-{2-(5-Isobutoxy-benzoimidazol-1-yl)-quinolin-8-yl}-piperidin-4-ylamine; 1-{2-(5-(Tetrahydro-pyran-4-yloxy)-benzoimidazol-1-yl]-quinolin-8-yI}-piperidin-4-ylamine; and the pharmaceutically acceptable salts, prodrugs, hydrates and solvates of the foregoing compounds. These compounds and their pharmaceutical compositions are suitable as antiproliferative agents and may be used for treating abnormal cell growth, such as cancer. The disclosure also relates to methods of preparing such benzomidazole derivative compounds.
Patent NZ-540009-A (NZ)
Title: Panel with hidden attachment means
Inventor: BROWNBILL ALAN
IPC: E04H17/14
Filed: 2004-09-17
Abstract: A panel (10) comprising a plurality of first members (11) disposed in a first direction, at least some of the first members defining a first part of a passageway, at least one second member (12) disposed in a second direction and including at least one passage portion (13) defining a second part of the passageway, the second member having a plurality of openings for at least partially receiving a first member, and at least one elongate locking member (14), adapted to pass through the passageway, wherein the passage portion has a periphery (15) which extends at least partially about the elongate locking member, with at least one opening (16) in a wall of the periphery to allow adjustment of the elongate locking member as it passes through the passage portion.
Patent NZ-546381-A (NZ)
Title: Crystalline form of gamma-aminobutyric acid analog
Inventor: ESTRADA TONO
IPC: A61K31/225
Filed: 2004-10-14
Abstract: A pharmaceutical composition comprising crystalline 1-{[(alpha-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid and a pharmaceutically acceptable vehicle wherein the crystalline 1-{[(alpha-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid has characteristic absorption peaks at 7.0 deg. ± 0.3 deg., 8.2deg. ± 0.3 deg.., 10.5 deg. ± 0.3 deg., 12.8 deg. ± 0.3 deg., 14.9 deg. ± 0.3 deg., and 16.4 deg. ± 0.3 deg. in an X-ray powder diffractogram using Cu Ka radiation. This crystalline form of a gamma-aminobutyric acid analog may be suitable for treating epilepsy, pain, depression, anxiety, psychosis, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, panic, inflammatory disease, insomnia, gastrointestinal disorders, hot flashes, restless legs syndrome, urinary incontinence or ethanol withdrawal syndrome.
Patent NZ-547786-A (NZ)
Title: Resource sharing broadband access system, methods and devices
Inventor: CRUZ RENE L
IPC: H04L12/28
Filed: 2004-12-17
Abstract: A method for providing shared communication resource access is disclosed. The method includes the steps of: (a) establishing a network of clients wherein a plurality of the clients (200-204), in the network of clients, have their own associated communication resource connection, (b) providing a communication protocol between the network of clients, (c) providing a protocol for sharing the communication resource connections of at least some of the clients to the network of clients, and (d) spreading communications from a client in the network of clients among the communication resource connections of the plurality of clients in the network.
Patent NZ-554573-A (NZ)
Title: A collapsible trailer
Inventor: SHAWYER ROBERT GORDON
Filed: 2007-04-18
Abstract: A collapsible trailer comprising a trailer frame, the trailer frame including at least one longitudinal member and at least a pair of transverse members and at least two wheels, the wheels removably associated with opposed ends of a first of the pair of transverse members and support means removably associated with the other of the pair of transverse members, the trailer frame being adapted to assume a use condition with the wheels attached for supporting a load on the trailer and a collapsed condition with the wheels removed in which the trailer occupies less space than in the use condition. The trailer may be adapted to support a boat or marine vessel.
Patent NZ-555450-A (NZ)
Title: Composition comprising disodium monocopper (II) citrate dihydrate and disodium monozinc (II) citrate dihydrate
Inventor: MAURER GERALD L
IPC: A01N55/02
Filed: 2005-10-25
Abstract: Disclosed is a palliative or therapeutic admixture for treating or medicating affected biological tissue in mammals, the admixture is comprised of effective amounts of at least two monometal complexes, each monometal complex comprising: a multivalent metal; and at least one polyfunctional organic ligand, wherein the ligand is in the form of an alkaline earth salt; wherein a molar ratio of metal to ligand is 1:1. Reference has been directed, in pursuance of Section 16(1) of the Patents Act 1953, to Patent No. 555451.
Patent NZ-562811-A (NZ)
Title: Anti-TNF antibodies, compositions, methods and uses
Inventor: GILES-KOMAR JILL
IPC: A61K39/00
Filed: 2001-08-01
Abstract: Disclosed is an antibody, or an antigen-binding fragment thereof, having three heavy chain complementary determining regions (CDRs) and three light chain CDRs, wherein each heavy chain CDR comprises the amino acid sequence of the corresponding heavy chain CDR of mAb TNV148 as described in Figure 4; and each light chain CDR of mAb TNV 148 as described in Figure 5.
Patent NZ-567729-A (NZ)
Title: Cleaning gas filters using a reverse gas flow and a shock wave pulse on selected filter segments
Inventor: ZIMMER SEBASTIAN
IPC: B01D46/04
Filed: 2006-10-10
Abstract: Process of cleaning filtration materials of a gas filter is disclosed. The gas filter consists of several filter segments (4) made of filtration material in a casing (1) and is provided with a slide plate (6). The slide plate (6) closes one more of the filter segments (4), which are located next to each other, and separates them from the normal filtered gas stream. Nozzle pipes (7) may introduce air in the reverse direction of normal flow to dislodge accumulated filtered material. The process has four steps: 1) Closing one or more filter segments (4) by moving the slide plate (6); 2) Providing a low pressure cleaning gas stream which ensures that the main filter-cake falls down in big chunks rather than airborne dust; 3) Providing a shock wave by a compressed gas impulse from the nozzle pipe (7) to achieve a cleaning vibration which dislodges any remaining material; 4) Shutting off the cleaning gas mentioned in 2).
Patent NZ-568218-A (NZ)
Title: An irrigator control system that uses irrigator position, water source information, and field information to control moving irrigators
Inventor: BRADBURY STUART FRANCIS
IPC: A01G25/09
Filed: 2008-05-12
Abstract: An irrigation system and a computer-implemented method of controlling an irrigation system are disclosed. The irrigation system includes one or more moving irrigators, water outlets on the irrigators to deliver water to an area to be irrigated, valves for controlling water flow through each of the outlets, one or more positioning systems to determine the position of the irrigators, and a controller. The controller receives inputs in the form of information relating to the water source, information relating to the area to be irrigated, and information relating to the irrigator position. Based on the aforementioned inputs, the controller controls the valves to change the water flow through the outlets.
Patent NZ-572335-A (NZ)
Title: Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
Inventor: JUNG MICHAEL E
IPC: A61K31/4166
Filed: 2007-03-27
Abstract: Disclosed is 4-(7-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3 ,4]octan-5-yI-4-methyl-benzene or 4-(7-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6- thioxo-5,7-diazaspiro[3 ,4]octan-5-yI-2-fluoro-N-methylbenzarnide or a pharmaceutically acceptable salt thereof for treating cancer.
Patent NZ-572771-A (NZ)
Title: A self-emulsifying composition for poorly bioavailable drugs
Inventor: NG BEE HONG
IPC: A61K31/05
Filed: 2007-06-15
Abstract: Disclosed is a drug delivery formulation comprising (a) an edible and pharmaceutically acceptable fatty acid e.g. oleic acid, eleostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, elaidic acid, linoleic acid, and docosahexaenoic acid.; (b) a non-ionic surfactant e.g. polyoxyethylene (20) sorbitan monooleate, polyoxyethylene (20) sorbitan monostearate, glyceryl polyethylene glycol oxystearate, glycerol polyethylene glycol ricinoleate, sucrose stearate, sucrose oleate, sucrose palmitate, sucrose myristate, sucrose laurate, decaglycerollauric acid esters, decaglycerol myristic acid esters, decaglycerol stearic acid esters.; and (c) a drug; wherein components (a) and (b) are miscible with each other and are in an isotropic mixture in a ratio ranging from 9.5:0.5 w/w to 9: 1 w/w and wherein neither a co-solvent nor an adjuvant is present in the formulation.
Patent NZ-575567-A (NZ)
Title: Single enantiomer beta agonists method for production and use thereof as a medicament
Inventor: KONETZKI INGO
IPC: A61P11/06
Filed: 2007-08-21
Abstract: Disclosed is an enantiomerically pure, solvent-free, crystalline form of a compound of formula 1-base e.g. N-(5-{ 2-[1,1-dimethyl-3-(2-oxo-4,4-dipropyl-4H-benzo[d][1,3]oxazin-1- yl)-propylamino]-1-hydroxy-ethyl} -2-hydroxy-phenyl)-methanesulphonamide wherein R1 and R2 which may be identical or different, denote ethyl or propyl, or together denote -CH2-CH2, -CH2-CH2-CH2, -CH2-CH2-CH2-CH2 or -CH2-CH2-CH2-CH2-CH2- and R3 represents hydrogen, fluorine, chlorine, OH, methyl, ethyl, methoxy or ethoxy for the treatment of a respiratory condition.
Patent NZ-575596-A (NZ)
Title: Coupling screen comprising an electrically conductive surface with two spaced apart projections
Inventor: DENNES WAYNE WILLIAM
IPC: H01R13/658
Filed: 2007-07-18
Abstract: An electromagnetic coupling reducing screen (60) is disclosed. The screen (60) reduces electromagnetic coupling between first and second pairs (62, 64) of electric connectors (52) that are arranged in a series of pairs of electric connectors (52) in a connector block. The screen (60) comprises first electrically conductive surface (66). The first electrically conductive surface (66) is shaped for arrangement between the first and second adjacent pairs (62, 64) of electric connectors (52). The first electrically conductive surface (66) includes two spaced apart projections (65, 67) that are arranged on its common end. The screen (60) further comprises two spaced apart electrically conductive surfaces (68, 70) that are electrically coupled to and extending transversally away from the respective sections of the electrically conductive surface (66) in a common direction, and forming three-sided screening for a pair of electric connectors (52).
Patent NZ-578281-A (NZ)
Title: 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands
Inventor: RAMAKRISHNA NIROGI VENKATA SATYA
IPC: A61K31/404
Filed: 2007-07-26
Abstract: Disclosed are indole compounds substituted at the N position by arylsulphonyl and at the 4 position by a piperazine derivative. The compounds are represented by formula (I) where the variables are as described in the disclosure. The compounds can be used to regulate the 5-HT6 receptor. Also disclosed is the process to make compounds of formula (I); pharmaceutical compositions comprising a compound of formula (I) and the use of a compound of formula (I) in the manufacture of a medicament for the treatment of anxiety, Alzheimer's disease, depression, obsessive-compulsive disorders, cognitive memory disorders, Parkinson's disease, schizophrenia, panic disorders, withdrawal from drug abuse syndrome, stroke, head trauma, neurodegenitive disorders gastrointestinal and/or obesity.
Patent NZ-588887-A (NZ)
Title: Cd151 antibodies used to treat cancer
Inventor: HAEUW JEAN-FRANCOIS
IPC: A61K39/395
Filed: 2009-04-08
Abstract: Disclosed is an isolated antibody, or one of its derivative compounds or functional fragments, capable of binding to the CD151 protein and of inhibiting tumour growth in vivo, comprising a heavy chain and a light chain, each of these chains comprising 3 CDRs, respectively, wherein said isolated antibody, or one of its derivative compounds or functional fragments, comprises, among its 6 CDRs, at least three CDRs selected from the CDRs of sequence SEQ ID No. 1-6, 17-22, 33-35, 43-48, 59-63, 69-73, 79-81 or 85-89 or at least three CDRs whose sequence has at least 80% identity, after optimal alignment, with the sequences SEQ ID No. 1-6, 17-22,33- 35, 43-48, 59-63,69-73, 79-81 or 85-89.
Patent NZ-592736-A (NZ)
Title: Acupuncture device including a needle rod to which an acupressure member is connected
Inventor: MUKHINA MARIYAT MURADALIYEVNA
IPC: A61H39/04
Filed: 2006-07-19
Abstract: A device when used in acupuncture reflexotherapy intended to cross a (human) body between two points of acupuncture, the device comprising an acupuncture member in the form of a needle rod and an acupressure member in the form of a plate (13) connected to the rod by an at least partially curved portion.
Patent NZ-601683-A (NZ)
Title: Heterocyclic-substituted piperidine compounds for modulating ORL-1 receptor function in a cell
Inventor: BABA YOSHIYASU
IPC: A61K31/498
Filed: 2008-01-15
Abstract: Disclosed are piperidine compounds that have a phenyl ring fused with a diaza heterocyclic ring of formula (II) wherein the substituent Q is naphthalene, and the variables are as defined in the specification. Also disclosed is a composition comprising a compound of formula (II), an in vitro method of modulating ORL-1 receptor function in a cell, the use of a compound of formula (II) in the manufacture of a medicament for treating pain, a memory disorder, obesity, constipation, urinary incontinence, anxiety, cough, diarrhoea, high blood pressure, epilepsy, anorexia/cachexia, or drug abuse; a kit comprising an amount of a compound of formula (II) and a method of preparing a composition comprising the steps of combining a compound of formula (II) with a pharmaceutically acceptable carrier or excipient.
Patent NZ-601738-A (NZ)
Title: Apixaban formulations
Inventor: PATEL JATIN
IPC: A61K9/20
Filed: 2011-02-24
Abstract: 601738 Disclosed herein are compositions comprising crystalline apixaban particles having a D90 equal to or less than 89 μm, and a pharmaceutically acceptable diluent or carrier. These compositions are useful in the treatment of thromboembolic disorders. Additionally discloses are processes for preparing the composition.